友華生技醫藥股份有限公司
友華生技醫藥股份有限公司（Orient EuroPharma Co., Ltd.）在全球研發製造藥品。處方藥涵蓋心血管、神經、及癌症。此外提供 Karihome（卡洛塔妮）羊奶粉、營養補充品及醫學美容保養品。亦涉及癌症免疫藥物研發。公司成立於 1982 年，總部位於台灣台北。
該股 RSI(6) 為 82.8，處於超買區間，短線漲多宜留意回檔風險。股價站上5日、20日、60日、120日均線。短中期均線呈多頭排列，趨勢偏多。KD 指標偏高（K=93.4），追高宜謹慎；MACD 柱狀體為正值，維持多方動能。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-11 | +7 | 0 | 0 | +7 |
| 08-10 | +7 | 0 | 0 | +7 |
| 08-07 | +4 | 0 | 0 | +4 |
| 08-06 | +18 | 0 | 0 | +18 |
| 08-05 | +71 | 0 | +2 | +71 |
| 08-04 | -1 | 0 | 0 | -1 |
| 08-03 | +29 | 0 | 0 | +29 |
| 07-31 | +8 | 0 | 0 | +8 |
| 07-30 | +1 | 0 | 0 | +1 |
| 07-29 | +14 | 0 | 0 | +14 |
| 07-28 | -4 | 0 | 0 | -4 |
| 07-27 | -4 | 0 | 0 | -4 |
| 07-24 | -12 | 0 | 0 | -12 |
| 07-23 | -5 | 0 | 0 | -5 |
| 07-22 | +15 | 0 | 0 | +15 |
| 07-21 | +2 | 0 | +1 | +2 |
| 07-20 | +4 | 0 | 0 | +4 |
| 07-17 | -11 | 0 | 0 | -11 |
| 07-16 | -7 | 0 | 0 | -7 |
| 07-15 | 0 | 0 | 0 | 0 |
| 07-14 | -8 | 0 | 0 | -8 |
| 07-13 | +16 | 0 | 0 | +16 |
| 07-09 | 0 | 0 | 0 | 0 |
| 07-08 | -8 | 0 | 0 | -9 |
| 07-07 | -7 | 0 | +1 | -6 |
| 07-06 | +3 | 0 | 0 | +3 |
| 07-03 | +7 | 0 | 0 | +7 |
| 07-02 | +12 | 0 | 0 | +12 |
| 07-01 | -14 | 0 | 0 | -14 |
| 06-30 | -20 | 0 | 0 | -20 |
| 06-29 | -5 | 0 | 0 | -5 |
| 06-26 | -4 | 0 | 0 | -4 |
| 06-25 | 0 | 0 | +8 | 0 |
| 06-24 | 0 | 0 | 0 | -2 |
| 06-23 | +4 | 0 | 0 | +4 |
| 06-22 | -3 | 0 | 0 | -3 |
| 06-18 | +3 | 0 | 0 | +3 |
| 06-17 | +1 | 0 | 0 | +1 |
| 06-16 | 0 | 0 | 0 | 0 |
| 06-15 | -4 | 0 | 0 | -4 |
| 06-12 | 0 | 0 | 0 | 0 |
| 06-11 | 0 | 0 | 0 | 0 |
| 06-10 | +2 | 0 | 0 | +2 |
| 06-09 | +2 | 0 | 0 | +2 |
| 06-08 | -1 | 0 | 0 | -2 |
| 06-05 | -9 | 0 | +2 | -9 |
| 06-04 | -1 | 0 | 0 | -1 |
| 06-03 | -14 | 0 | +10 | -14 |
| 06-02 | -3 | 0 | 0 | -3 |
| 06-01 | -21 | 0 | 0 | -21 |
| 05-29 | 0 | 0 | 0 | 0 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/04 | 3.95 億 | -0.9% | +5.2% |
| 2026/03 | 3.99 億 | +31.1% | +7.4% |
| 2026/02 | 3.04 億 | -31.6% | -14.9% |
| 2026/01 | 4.45 億 | +15.0% | +4.4% |
| 2025/12 | 3.87 億 | +4.5% | +14.4% |
| 2025/11 | 3.71 億 | -15.4% | -7.3% |
| 2025/10 | 4.38 億 | +10.7% | +13.5% |
| 2025/09 | 3.96 億 | +6.9% | +17.0% |
| 2025/08 | 3.70 億 | +6.0% | -2.2% |
| 2025/07 | 3.49 億 | -2.5% | -0.9% |
| 2025/06 | 3.58 億 | -8.7% | +3.4% |
| 2025/05 | 3.92 億 | - | +11.0% |